Protein therapeutics: a summary and pharmacological classification
- PMID: 18097458
- DOI: 10.1038/nrd2399
Protein therapeutics: a summary and pharmacological classification
Abstract
Once a rarely used subset of medical treatments, protein therapeutics have increased dramatically in number and frequency of use since the introduction of the first recombinant protein therapeutic--human insulin--25 years ago. Protein therapeutics already have a significant role in almost every field of medicine, but this role is still only in its infancy. This article overviews some of the key characteristics of protein therapeutics, summarizes the more than 130 protein therapeutics used currently and suggests a new classification of these proteins according to their pharmacological action.
Similar articles
-
Darbepoetin alfa: a novel erythropoiesis-stimulating protein.Drugs Today (Barc). 2003 Jul;39(7):477-95. doi: 10.1358/dot.2003.39.7.799441. Drugs Today (Barc). 2003. PMID: 12973399 Review.
-
Evaluation of the US Oncology Network's recommended guidelines for therapeutic substitution with darbepoetin alfa 200 microg every 2 weeks in both naïve patients and patients switched from epoetin alfa.Pharmacotherapy. 2004 Mar;24(3):313-23. doi: 10.1592/phco.24.4.313.33180. Pharmacotherapy. 2004. PMID: 15040644
-
Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.Diabetes Care. 2007 May;30(5):1187-92. doi: 10.2337/dc06-1915. Epub 2007 Mar 2. Diabetes Care. 2007. PMID: 17337503
-
Optimizing the use of erythropoietic agents-- pharmacokinetic and pharmacodynamic considerations.Nephrol Dial Transplant. 2002;17 Suppl 5:66-70. doi: 10.1093/ndt/17.suppl_5.66. Nephrol Dial Transplant. 2002. PMID: 12091611 Review.
-
Pharmacogenetics of cystic fibrosis treatment.Pharmacogenomics. 2016 Aug;17(13):1453-63. doi: 10.2217/pgs.16.25. Epub 2016 Aug 4. Pharmacogenomics. 2016. PMID: 27490265 Review.
Cited by
-
Examining the Effect of Polymer Extension on Protein-Polymer Interactions That Occur during Formulation of Protein-Loaded Poly(lactic acid-co-glycolic acid)-polyethylene Glycol Nanoparticles.Polymers (Basel). 2022 Nov 4;14(21):4730. doi: 10.3390/polym14214730. Polymers (Basel). 2022. PMID: 36365724 Free PMC article.
-
Evaluation of an Affinity-Enhanced Anti-SARS-CoV2 Nanobody Design Workflow Using Machine Learning and Molecular Dynamics.J Chem Inf Model. 2024 Oct 14;64(19):7626-7638. doi: 10.1021/acs.jcim.4c01023. Epub 2024 Oct 2. J Chem Inf Model. 2024. PMID: 39356775 Free PMC article.
-
Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges.Int J Nanomedicine. 2015 Feb 17;10:1399-414. doi: 10.2147/IJN.S74514. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25733832 Free PMC article. Review.
-
Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy.Front Bioeng Biotechnol. 2022 Sep 6;10:994655. doi: 10.3389/fbioe.2022.994655. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36147526 Free PMC article. Review.
-
A stimulus-responsive hexahedron DNA framework facilitates targeted and direct delivery of native anticancer proteins into cancer cells.Chem Sci. 2022 Aug 13;13(37):11132-11139. doi: 10.1039/d2sc02858a. eCollection 2022 Sep 28. Chem Sci. 2022. PMID: 36320481 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources